MedTrace Logo

Dermal Micrografts in Regenerative Surgery

NCT03912675 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-04-11

No results posted yet for this study

Summary

Objective assessment of the effectiveness of a micro-fragmented dermal extract obtained with Rigenera™ technology (patented by Human Brain Wave) in promoting the wound healing process in an in-vivo homogeneous experimental human acute surgical wound model.

Conditions

  • Regenerative Medicine

Interventions

PROCEDURE

Integra® dermal substitute and RigeneraTM protocol

Integra® dermal substitute enriched with the autologous dermal micro-grafts obtained with RigeneraTM protocol

Sponsors & Collaborators

  • Istituti Clinici Scientifici Maugeri SpA

    lead OTHER

Principal Investigators

  • Angela Faga, Professor · Università degli Studi di Pavia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-11
Primary Completion
2018-09-30
Completion
2019-01-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03912675 on ClinicalTrials.gov